JPH04126079A - Carboxypeptidase b-like enzyme originated from microorganism - Google Patents
Carboxypeptidase b-like enzyme originated from microorganismInfo
- Publication number
- JPH04126079A JPH04126079A JP24478090A JP24478090A JPH04126079A JP H04126079 A JPH04126079 A JP H04126079A JP 24478090 A JP24478090 A JP 24478090A JP 24478090 A JP24478090 A JP 24478090A JP H04126079 A JPH04126079 A JP H04126079A
- Authority
- JP
- Japan
- Prior art keywords
- enzyme
- activity
- arginine
- carboxypeptidase
- lysine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102000004190 Enzymes Human genes 0.000 title claims abstract description 97
- 108090000790 Enzymes Proteins 0.000 title claims abstract description 97
- 102000005367 Carboxypeptidases Human genes 0.000 title claims abstract description 11
- 108010006303 Carboxypeptidases Proteins 0.000 title claims abstract description 11
- 244000005700 microbiome Species 0.000 title description 3
- 230000000694 effects Effects 0.000 claims abstract description 45
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 24
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Chemical group NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims abstract description 15
- 239000004475 Arginine Substances 0.000 claims abstract description 12
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims abstract description 12
- 241000221955 Chaetomium Species 0.000 claims abstract description 11
- 239000004472 Lysine Chemical group 0.000 claims abstract description 9
- 125000000637 arginyl group Chemical group N[C@@H](CCCNC(N)=N)C(=O)* 0.000 claims abstract description 4
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 claims description 17
- 239000000758 substrate Substances 0.000 claims description 16
- 239000000872 buffer Substances 0.000 claims description 12
- 210000004899 c-terminal region Anatomy 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 8
- 230000007062 hydrolysis Effects 0.000 claims description 6
- 238000006460 hydrolysis reaction Methods 0.000 claims description 6
- 238000002523 gelfiltration Methods 0.000 claims description 4
- 101800004538 Bradykinin Proteins 0.000 claims description 2
- 102400000967 Bradykinin Human genes 0.000 claims description 2
- QXZGBUJJYSLZLT-UHFFFAOYSA-N H-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH Natural products NC(N)=NCCCC(N)C(=O)N1CCCC1C(=O)N1C(C(=O)NCC(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CO)C(=O)N2C(CCC2)C(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CCCN=C(N)N)C(O)=O)CCC1 QXZGBUJJYSLZLT-UHFFFAOYSA-N 0.000 claims description 2
- QXZGBUJJYSLZLT-FDISYFBBSA-N bradykinin Chemical compound NC(=N)NCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(=O)NCC(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CO)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)CCC1 QXZGBUJJYSLZLT-FDISYFBBSA-N 0.000 claims description 2
- PCJGZPGTCUMMOT-ISULXFBGSA-N neurotensin Chemical group C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(O)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1NC(=O)CC1)C1=CC=C(O)C=C1 PCJGZPGTCUMMOT-ISULXFBGSA-N 0.000 claims description 2
- FJPHHBGPPJXISY-KBPBESRZSA-N (2s)-2-[[(2s)-2-[[2-[(2-aminoacetyl)amino]acetyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-5-(diaminomethylideneamino)pentanoic acid Chemical compound NC(N)=NCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CNC(=O)CN)CC1=CC=C(O)C=C1 FJPHHBGPPJXISY-KBPBESRZSA-N 0.000 claims 1
- 108010065713 glycyl-glycyl-tyrosyl-arginine Proteins 0.000 claims 1
- 230000001580 bacterial effect Effects 0.000 abstract description 11
- 238000012258 culturing Methods 0.000 abstract description 5
- 238000004519 manufacturing process Methods 0.000 abstract description 5
- 230000000813 microbial effect Effects 0.000 abstract description 4
- 241000088530 Chaetomium sp. Species 0.000 abstract description 2
- 239000007853 buffer solution Substances 0.000 abstract description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 22
- 239000002609 medium Substances 0.000 description 17
- 102000004196 processed proteins & peptides Human genes 0.000 description 14
- 239000000284 extract Substances 0.000 description 12
- 235000002639 sodium chloride Nutrition 0.000 description 12
- 150000001413 amino acids Chemical class 0.000 description 11
- 239000011780 sodium chloride Substances 0.000 description 11
- 239000000243 solution Substances 0.000 description 11
- 244000061456 Solanum tuberosum Species 0.000 description 10
- 235000002595 Solanum tuberosum Nutrition 0.000 description 10
- 210000004027 cell Anatomy 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 229920001817 Agar Polymers 0.000 description 7
- 239000008272 agar Substances 0.000 description 7
- -1 aromatic amino acid Chemical class 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 5
- 229930006000 Sucrose Natural products 0.000 description 5
- 125000000539 amino acid group Chemical group 0.000 description 5
- 239000002244 precipitate Substances 0.000 description 5
- 239000005720 sucrose Substances 0.000 description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 239000012614 Q-Sepharose Substances 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 238000000354 decomposition reaction Methods 0.000 description 4
- 238000010828 elution Methods 0.000 description 4
- 238000005194 fractionation Methods 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 210000004209 hair Anatomy 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 description 4
- YFZOUMNUDGGHIW-UHFFFAOYSA-M p-chloromercuribenzoic acid Chemical compound OC(=O)C1=CC=C([Hg]Cl)C=C1 YFZOUMNUDGGHIW-UHFFFAOYSA-M 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 230000004913 activation Effects 0.000 description 3
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 3
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 3
- 235000011130 ammonium sulphate Nutrition 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000004587 chromatography analysis Methods 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000000502 dialysis Methods 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 239000006877 oatmeal agar Substances 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 239000012521 purified sample Substances 0.000 description 3
- 238000011218 seed culture Methods 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- GFLCPYUSPYXNBV-NSHDSACASA-N (2s)-2-[(2-benzamidoacetyl)amino]-5-(diaminomethylideneamino)pentanoic acid Chemical compound NC(N)=NCCC[C@@H](C(O)=O)NC(=O)CNC(=O)C1=CC=CC=C1 GFLCPYUSPYXNBV-NSHDSACASA-N 0.000 description 2
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 2
- BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 240000007817 Olea europaea Species 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 238000005273 aeration Methods 0.000 description 2
- 210000001557 animal structure Anatomy 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 239000003480 eluent Substances 0.000 description 2
- 238000006911 enzymatic reaction Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 238000005342 ion exchange Methods 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 238000000691 measurement method Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000004570 mortar (masonry) Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000004576 sand Substances 0.000 description 2
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 238000000967 suction filtration Methods 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- KSSUQRNDILYZSB-UHFFFAOYSA-N 2-iodoacetic acid Chemical compound ICC(=O)O.ICC(=O)O KSSUQRNDILYZSB-UHFFFAOYSA-N 0.000 description 1
- 241000258957 Asteroidea Species 0.000 description 1
- 125000001433 C-terminal amino-acid group Chemical group 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 102000003670 Carboxypeptidase B Human genes 0.000 description 1
- 108090000087 Carboxypeptidase B Proteins 0.000 description 1
- 241001494491 Chaetomiaceae Species 0.000 description 1
- 241000251730 Chondrichthyes Species 0.000 description 1
- 229910021580 Cobalt(II) chloride Inorganic materials 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 235000019733 Fish meal Nutrition 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 102000001399 Kallikrein Human genes 0.000 description 1
- 108060005987 Kallikrein Proteins 0.000 description 1
- 108010093008 Kinins Proteins 0.000 description 1
- 102000002397 Kinins Human genes 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical group NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- MQUQNUAYKLCRME-INIZCTEOSA-N N-tosyl-L-phenylalanyl chloromethyl ketone Chemical compound C1=CC(C)=CC=C1S(=O)(=O)N[C@H](C(=O)CCl)CC1=CC=CC=C1 MQUQNUAYKLCRME-INIZCTEOSA-N 0.000 description 1
- 241000233855 Orchidaceae Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 240000004713 Pisum sativum Species 0.000 description 1
- 235000010582 Pisum sativum Nutrition 0.000 description 1
- 235000019779 Rapeseed Meal Nutrition 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 108091006629 SLC13A2 Proteins 0.000 description 1
- 241000872198 Serjania polyphylla Species 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- DGEZNRSVGBDHLK-UHFFFAOYSA-N [1,10]phenanthroline Chemical compound C1=CN=C2C3=NC=CC=C3C=CC2=C1 DGEZNRSVGBDHLK-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- OYHLRJGDELITAF-INIZCTEOSA-N benzyl n-[(2s)-4-chloro-3-oxo-1-phenylbutan-2-yl]carbamate Chemical compound C([C@@H](C(=O)CCl)NC(=O)OCC=1C=CC=CC=1)C1=CC=CC=C1 OYHLRJGDELITAF-INIZCTEOSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 235000011148 calcium chloride Nutrition 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000009920 chelation Effects 0.000 description 1
- 239000007979 citrate buffer Substances 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Substances OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 239000013256 coordination polymer Substances 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 229940099112 cornstarch Drugs 0.000 description 1
- 208000031513 cyst Diseases 0.000 description 1
- 239000000385 dialysis solution Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000004467 fishmeal Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000000415 inactivating effect Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 125000003588 lysine group Chemical group [H]N([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 229940062190 pancreas extract Drugs 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- AVTYONGGKAJVTE-OLXYHTOASA-L potassium L-tartrate Chemical compound [K+].[K+].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O AVTYONGGKAJVTE-OLXYHTOASA-L 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 239000001472 potassium tartrate Substances 0.000 description 1
- 229940111695 potassium tartrate Drugs 0.000 description 1
- 235000011005 potassium tartrates Nutrition 0.000 description 1
- 235000012015 potatoes Nutrition 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 125000006239 protecting group Chemical group 0.000 description 1
- 239000004456 rapeseed meal Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 238000005185 salting out Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000004317 sodium nitrate Substances 0.000 description 1
- 235000010344 sodium nitrate Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 229940001941 soy protein Drugs 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
- 239000011686 zinc sulphate Substances 0.000 description 1
- 235000009529 zinc sulphate Nutrition 0.000 description 1
Landscapes
- Enzymes And Modification Thereof (AREA)
Abstract
Description
【発明の詳細な説明】
(産業上の利用分野)
本発明は新規な微生物起源カルボキシペプチダーゼB様
酵素に関する。DETAILED DESCRIPTION OF THE INVENTION (Field of Industrial Application) The present invention relates to a novel carboxypeptidase B-like enzyme of microbial origin.
(従来の技術)
カルボキシペプチダーゼB(以下、CPa5e Bとす
る)はすでに知られており(J、E、Folk、The
Enzyraes (3rd ed、)357〜79
(1971) ) 、このC’Pa5e Bは、ペ
プチドのC末端のアルギニンまたはリシンを切断するた
め、タンパクの一次構造解析用の生化学試薬として汎用
されている。さらに、このCPa5e Bは、例えばキ
ニン(Kinin)の不活化作用を有するため、医薬品
としての用途などが期待される。(Prior art) Carboxypeptidase B (hereinafter referred to as CPa5e B) is already known (J.E., Folk, The.
Enzyraes (3rd ed,) 357-79
(1971) ), this C'Pa5e B cleaves arginine or lysine at the C-terminus of peptides, and is therefore widely used as a biochemical reagent for analyzing the primary structure of proteins. Furthermore, since CPa5e B has an inactivating effect on, for example, kinin, it is expected to be used as a pharmaceutical.
CPa5e Bはヒト、ラン、ブタ、ラットの膵臓、サ
メ、ヒトデなどに存在し、ブタ膵臓抽出物を原料とした
ものが市販されている。しかし膵臓抽出物は他の酵素、
例えば、カリクレインおよびトリプシンを含んでいるた
め、工業的なスケールでこの両方の酵素とCPa5e
Bとを分離するには、非常に大きな経費を必要とする。CPa5e B exists in the pancreas of humans, orchids, pigs, rats, sharks, starfish, etc., and products made from porcine pancreas extract are commercially available. However, pancreatic extract contains other enzymes,
For example, since it contains kallikrein and trypsin, both enzymes and CPa5e can be used on an industrial scale.
Separating it from B would require a very large expense.
さらに、動物臓器は酵素製造原料として資源的に工業規
模の生産には適していないという欠点がある。Furthermore, animal organs have the disadvantage that they are not suitable as raw materials for enzyme production in terms of resources for industrial scale production.
(発明が解決しようとする課題)
本発明は、上記従来の課題を解決するものであり、その
目的とするところは、動物臓器由来のCPa5e Bに
かわる微生物起源のCPa5e B様酵素を提供するこ
とにある。(Problems to be Solved by the Invention) The present invention solves the above-mentioned conventional problems, and its purpose is to provide a CPa5e B-like enzyme derived from a microorganism to replace CPa5e B derived from animal organs. It is in.
(課題を解決するための手段)
本発明者らは、上記の目的を達成すべく、種々の微生物
を検索した結果、大阪府冨田林市の土壌中から採取され
たChaetomium (ケトミウム)に属するCh
aetosium sp、 F−33が目的とするカル
ボキシペプチダーゼの性質を有する酵素を生産すること
を見い出した。そして、この酵素を精製し、その性質を
詳細に検討した結果、新しいタイプのcPase B様
酵素であることをlIN!認し、本発明を完成するに至
った。(Means for Solving the Problems) In order to achieve the above object, the present inventors searched for various microorganisms, and found that Ch belonging to Chaetomium was collected from the soil of Tomitabayashi City, Osaka Prefecture.
It has been found that aetosium sp. F-33 produces an enzyme having the desired properties of carboxypeptidase. After purifying this enzyme and examining its properties in detail, we discovered that it is a new type of cPase B-like enzyme! This led to the completion of the present invention.
本発明のCPa5e B様酵素は、次の性質を有する。The CPa5e B-like enzyme of the present invention has the following properties.
(1)作用:カルボキシ末端がアルギニンまたはリシン
であるペプチドの8亥末端のアルギニンまた:よリシン
を、加水分解により遊離させる。(1) Action: The 8-terminal arginine or lysine of a peptide whose carboxy terminus is arginine or lysine is released by hydrolysis.
(2)基質特異性ニゲリシル−グリシル−チロシルアル
ギニン、ブラジキニン、ニューロテンシン断片1−8に
作用し、C末端のアルギニンを加水分解により遊離させ
る。(2) Substrate specificity Acts on nigericyl-glycyl-tyrosyl arginine, bradykinin, and neurotensin fragment 1-8, and releases C-terminal arginine by hydrolysis.
(3)至適pH:約8.5(トリス−塩酸緩衝液中)。(3) Optimum pH: about 8.5 (in Tris-HCl buffer).
(4)至適温度=55℃
(5)p H安定性:25℃にて9時間保持した場合に
、pH7〜10において安定である。(4) Optimum temperature = 55°C (5) pH stability: Stable at pH 7 to 10 when kept at 25°C for 9 hours.
(6)熱安定性:4℃,pH7,5にて保持すると、少
なくとも1年間は100%の活性を示す。(6) Thermal stability: When maintained at 4°C and pH 7.5, it shows 100% activity for at least 1 year.
55℃で5時間加熱した場合に、90%の残存活性を示
す。It shows 90% residual activity when heated at 55°C for 5 hours.
(力分子量ニゲル濾過法により測定した場合の分子量は
約45万である。(The molecular weight is approximately 450,000 when measured by Nigel filtration method.
(8)等電点: 5.49
本発明のCPa5e B様酵素はChaetomium
属菌、特にChaetomium sp、 F−33株
により生産される。この菌株は、発明者らにより大阪府
冨田林市より採取された土壌中から単離された新菌株で
ある。この菌株の菌学的性質を次に示す。(8) Isoelectric point: 5.49 The CPa5e B-like enzyme of the present invention is Chaetomium
Chaetomium sp., especially Chaetomium sp, strain F-33. This strain is a new strain isolated by the inventors from soil collected from Tomitabayashi City, Osaka Prefecture. The mycological properties of this strain are shown below.
(A)培地における生育状態
■肉汁寒天培地
肉汁寒天培地での生育は5℃では全く起こらない。30
℃では7日間でコロニーの直径が4.7〜5.71に達
する。性状は白い綿状である。14日間の培養でコロニ
ーの直径は7〜8CI11に達する。21日間の培養で
表面は密になり湿った状態の羊毛状となるが、着色は見
られず子のう殻も形成されない。(A) Growth status on culture medium ■ Broth agar medium Growth on broth agar medium does not occur at all at 5°C. 30
℃, the colony diameter reaches 4.7-5.71 mm in 7 days. Its appearance is white and cotton-like. After 14 days of culture, the colony diameter reaches 7-8 CI11. After 21 days of culture, the surface becomes dense and moist and woolly, but no coloration is observed and no pericarp is formed.
37℃では生育が悪く成熟に至らない。Growth is poor at 37°C and does not reach maturity.
■ツアペック寒天培地
ツアペ、り寒天培地での生育は5℃では全く起こらない
。30℃では7日間でコロニーの直径が4〜5cmに達
する。性状は白い綿状であり、肉汁寒天培地上のコロニ
ーに比べて湿状態となる。14日間の培養ではコロニー
の直径が7〜80I11に達し、部分的に黒縁色となる
。30日の培養でほぼ全体的に黒縁色となる。子のう殻
の形成は見られない。■Tsapek agar medium Growth on Tsapek agar medium does not occur at all at 5°C. At 30°C, the colony diameter reaches 4-5 cm in 7 days. The colony is white and cotton-like, and is wetter than the colony on the broth agar medium. After 14 days of culture, the colonies reach a diameter of 7 to 80I11 and have a partially black border color. After 30 days of culture, the color becomes almost entirely black. No ascus formation is observed.
■オートミール寒天培地 オートミール寒天培地での生育は5℃では起こらない。■Oatmeal agar medium Growth on oatmeal agar does not occur at 5°C.
30℃では7日間でコロニーの直径は5〜6C11に達
し、性状は羊毛状となる。14日間でコロニーの7直径
は7〜8C11に達し裏面が暗オリーブ緑色〜緑黄色と
なる。At 30°C, the diameter of the colony reaches 5 to 6C11 in 7 days, and the colony becomes woolly in appearance. In 14 days, the diameter of the colony reaches 7-8C11, and the underside becomes dark olive green to greenish-yellow.
■ポテト・グルコース寒天培地
ポテト・グルコース寒天培地での生育は5 ’Cでは起
こらない。23℃では9日間でコロニーの直径は4〜5
C1+に達し、性状は白い綿状である。14日間ではコ
ロニーの直径は6.5〜7.5 cmに達する。■Potato glucose agar medium Growth on potato glucose agar medium does not occur at 5'C. At 23°C, the diameter of colonies is 4-5 in 9 days.
It reaches C1+ and has a white cotton-like appearance. Colonies reach a diameter of 6.5-7.5 cm in 14 days.
中心部と円周部を残し、中間部の内部は黒縁色となり、
中心部の裏面は黒かっ色となる。それにともなって全体
が湿った状態となり、着色部に油味を生しる。子のうは
多く認められるが子のう胞子は少ない。黒縁色の部分↓
二子のう殻の形成が認められる。Leaving the center and circumference, the inside of the middle part has a black border color,
The back side of the center is blackish brown. As a result, the entire product becomes wet and the colored portions have an oily taste. Many asci are observed, but ascospores are rare. Black edged part↓
Formation of cysts in two children is observed.
(B)生理的、生態的性質
■最適生育条件
pH5〜7
温度 23゛C〜27゛C
■生育の範囲
pi(4〜8
温度 15゛C〜37゛C
■その他の顕著な特徴
ポテト・グルコース培地での培養により、カルボキシペ
プチダーゼB様酵素を菌体内に生産する。(B) Physiological and ecological properties ■Optimal growth conditions pH 5-7 Temperature 23°C-27°C ■Growth range pi (4-8 Temperature 15°C-37°C ■Other notable characteristics Potato glucose By culturing in a medium, a carboxypeptidase B-like enzyme is produced within the bacterial cells.
(C)顕微鏡的所見
■子のう殻:若いうちは透明であり、成熟すると黒縁色
となる。卵形〜弁球形で大きさは200〜240 X1
50〜200 utaである。(C) Microscopic findings ■ Percipitum: Transparent when young, and becomes black-rimmed when mature. Oval to bulb shaped, size 200 to 240 x 1
It is 50-200 uta.
■頂毛:暗オリーブかっ色〜はとんど黒色で隔壁があり
、直毛である。はぼ直角に分枝し、複雑な網目を形成す
る。先細にならずふっつりした先端におわる。基部での
幅7〜7.5μ憚。■ Crown hair: Dark olive-brown to almost black with septa and straight hair. It branches at right angles, forming a complex network. Ends at a plump tip without tapering. Width at base: 7-7.5μ.
■倒毛:頂毛に類イ以するが幅は狭い。基部での幅5〜
6μ隣。■Filthy hairs: similar to apical hairs, but narrower in width. Width at base 5~
Next to 6μ.
■子のう:こん棒形 8胞子
■子のう胞子:最初は無色で、後に暗オリーフかっ色と
なる。幅広いだ円形〜円形。6〜マX4〜6μm。■Ascospores: Club-shaped, 8 spores■Ascospores: Colorless at first, later becoming dark olive-brown. Wide oval to circular shape. 6-ma x 4-6 μm.
上記菌学的性質に基づいて、「ア・モノグラフ・オブ・
ケトミウム(A monograph of the
genuschaetomium) J (1970)
〔セス(HJ、5eth) ’J、1ケトミアシエ(
Chaetomiaceae) J (1963)
(アメス (1、M、An+es) ) 、および「菌
類図鑑(下) J (1978)〔椿 啓介他〕を参照
し、これを検索したところ本菌株はケトミウムに属する
と判断された。本菌株はケトミウム・スビノスムにi(
以するがケトミウム・スピノスムは子のう胞子が卯形で
あり (上記文献に記載)、本菌株式会社では幅広いだ
円形〜円形であることが異なる。さらに、ケトミウム・
スピノスムは37℃では生育せず、オートミール寒天培
地上で灰黄かっ色になる(上記文献に記載)のに対して
、本菌株では裏面が暗オリーブ緑色〜緑黄色となり、3
7℃て生育は悪いが生育可能である点で異なる。Based on the above mycological properties, “A Monograph of
Ketomium (A monograph of the
genuschaetomium) J (1970)
[Seth (HJ, 5eth) 'J, 1 Ketomiashie (
Chaetomiaceae) J (1963)
(Ames (1, M, An+es)) and "Illustrated Encyclopedia of Fungi (Part 2) J (1978) [Keisuke Tsubaki et al.], and when searching this, it was determined that this strain belongs to Chaetomium. i to Chaetomium subinosum (
However, the difference is that the ascospores of Chaetomium spinosum are rabbit-shaped (described in the above-mentioned literature), whereas the ascospores of Chaetomium spinosum are broadly oval to circular. In addition, ketomium
Spinosum does not grow at 37°C and turns grayish-yellowish on oatmeal agar medium (described in the above-mentioned literature), whereas the underside of this strain turns dark olive green to greenish-yellow;
It is different in that it grows poorly at 7°C, but can grow.
従って、本発明者は本菌株をChaetomium (
ケトミウム) sp、 F−33と命名した。本菌株は
、工業技術院微生物工業技術研究所に、微工研菌寄第1
1717号(FERM P−11717)として寄託さ
れている。Therefore, the present inventors identified this strain as Chaetomium (
Chaetomium) sp, was named F-33. This strain was transferred to the National Institute of Microbiology, Agency of Industrial Science and Technology,
No. 1717 (FERM P-11717).
本明細書においてアミノ酸、ペプチド、保護基等の略号
による表示は当該分野における慣用記号に従うものとす
る。In this specification, abbreviations for amino acids, peptides, protecting groups, etc. shall follow the symbols commonly used in the field.
囲1条註
本発明のCPa5e B様酵素を製造するために生産菌
株を培養するための培地は格別である必要はな(、通常
の培地が用いられる。炭素源としてグルコース、シュー
クロース、グリセロール、デンプンなどが用いられる。Notes to Article 1: The medium for culturing the production strain to produce the CPa5e B-like enzyme of the present invention does not need to be special (a normal medium can be used. As a carbon source, glucose, sucrose, glycerol, Starch etc. are used.
窒素源として肉エキス、酵母エキス、麦芽エキス、ポリ
ペプトン、カザミノ酸、各種アミノ酸、総合アミノ酸、
ダイズタンパク、魚粉などが用いられる。塩類としては
、NaCl、KCl、酒石酸カリウム、硝酸ナトリウム
、リン酸−カリウム、硫酸マグネシウム、塩化カルシウ
ムなどが用いられる。その他、ふすま、米糠、菜種粕、
糖蜜、コーンステイープリカー、ポテトエキス、ビタミ
ン類なども有用である。Meat extract, yeast extract, malt extract, polypeptone, casamino acids, various amino acids, general amino acids,
Soy protein, fish meal, etc. are used. As the salts, NaCl, KCl, potassium tartrate, sodium nitrate, potassium phosphate, magnesium sulfate, calcium chloride, etc. are used. Others include bran, rice bran, rapeseed meal,
Molasses, cornstarch liquor, potato extract, and vitamins are also useful.
特に、零カルボキシペプチダーゼB様酵素(以下、CP
a5e B様酵素とする)生産菌の培養(種培養および
生産用培養を含む)の培地として好適に用いられる培地
としては、ポテトエキス・シェークロース培地が好適で
ある(実施例で詳述する)。In particular, zero carboxypeptidase B-like enzyme (hereinafter referred to as CP
Potato extract/shakerose medium is suitable as a medium for culturing (including seed culture and production culture) of producing bacteria (a5e B-like enzyme) (described in detail in Examples). .
培養はpl(5〜7、好ましくはpl(6付近で、25
℃〜37℃1好ましくは30℃にて、振とうまたは通気
攪拌下にて行われる。培養時間は、例えば坂ロフラスコ
を用いた場合には、40〜100時間が適当であり、フ
ァーメンタ−を用いた場合には45〜50時間が適当で
ある。Culture is carried out at pl (5 to 7, preferably around pl (6, 25
C. to 37.degree. C., preferably 30.degree. C., with shaking or stirring under aeration. The culture time is, for example, 40 to 100 hours when using a Sakaro flask, and 45 to 50 hours when using a fermentor.
群!■採取叛
本CPa5e B様酵素は主に菌体内に存在するので、
培養終了後、ろ過あるいは遠心分離などにより集菌した
後、菌体を破砕して酵素の抽出を行う。例えば、ガラス
ピーズ、海砂などの共存下で、菌体を乳鉢、ボールミル
などを用いて磨砕する方法(市販装置としてダイノミル
A、 Bachofen社がある凍結融解法、酵素処理
法などがあげられる。菌体の破砕法は特に限定されない
が回収率の高い方法が好ましい。菌体破砕後は緩衝液を
加えた後ろ過し、あるいは遠心分離を行うことにより粗
酵素液が得られる。group! ■Collection of CPa5e B-like enzymes mainly exist within the bacterial body, so
After culturing, the bacteria are collected by filtration or centrifugation, and the enzymes are extracted by crushing the cells. For example, a method of grinding the bacterial cells using a mortar, a ball mill, etc. in the presence of glass peas, sea sand, etc. (commercially available devices include Dyno Mill A, a freeze-thaw method available from Bachofen, and an enzyme treatment method). The method of disrupting the bacterial cells is not particularly limited, but a method with a high recovery rate is preferred.After disrupting the bacterial cells, a buffer solution is added and then filtered or centrifuged to obtain a crude enzyme solution.
この粗酵素液から精製酵素を得るには、通常、酵素の精
製に用いられている方法が単独で、もしくは組合わせて
用いられ得る。それには例えば、塩析、溶媒沈澱、各種
イオン交換カラムクロマトグラフィー、疎水クロマトグ
ラフィー、ゲル濾過法、アフィニティークロマトグラフ
ィー、遠心分離、電気泳動法などが挙げられる。例えば
、粗酵素液を硫安分画し、次いで、エタノール分画を行
い、クロマトグラフィーにかけ、そしてゲル濾過を行う
ことにより精製酵素が得られる。上記クロマトグラフィ
ー処理としては、例えば、まず、イオン交換カラム (
Q−セファロース、DEAE トーヨーバールなど)に
かけ、次いで、疎水カラム(プチルトーヨーパールなど
)にかける方法が挙げられる。上記ケル濾過担体として
はトーヨーパールH−55Sなどがある。To obtain a purified enzyme from this crude enzyme solution, methods commonly used for enzyme purification may be used alone or in combination. Examples thereof include salting out, solvent precipitation, various ion exchange column chromatography, hydrophobic chromatography, gel filtration, affinity chromatography, centrifugation, and electrophoresis. For example, a purified enzyme can be obtained by subjecting a crude enzyme solution to ammonium sulfate fractionation, followed by ethanol fractionation, chromatography, and gel filtration. As for the above chromatography treatment, for example, first, an ion exchange column (
Q-Sepharose, DEAE Toyovar, etc.) and then a hydrophobic column (Butyl Toyopal, etc.). Examples of the Kel filtration carrier include Toyo Pearl H-55S.
屑血」すを去
30tMBz−Gly−Arg O,1rxi!と10
0mM トリス−塩酸(pH8,5) 0.85mの
混液に酵素液0.05yriを加え、55℃で反応を開
始させる。15分間反応後、これを速やかに水冷したの
ち、200mtlクエン酸緩衝液(pH5,0)を1r
IIlとニンヒドリン試薬1〆とを順次加えて、すばや
く攪拌し、反応を停止させる。得られた反応液を沸騰水
中で5分間加熱した後、氷冷する。これに60%(v/
v)エタノール2 dを加え、十分に混合した後、57
0na+における吸収を測定する。30tMBz-Gly-Arg O, 1rxi! and 10
Add 0.05 yri of the enzyme solution to a 0.85 m mixture of 0 mM Tris-HCl (pH 8.5) and start the reaction at 55°C. After reacting for 15 minutes, this was quickly cooled with water, and then 1r of 200ml citrate buffer (pH 5,0) was added.
Add IIl and 1 part of ninhydrin reagent sequentially and stir quickly to stop the reaction. The resulting reaction solution is heated in boiling water for 5 minutes and then cooled on ice. Add to this 60% (v/
v) After adding 2 d of ethanol and mixing thoroughly, 57
Measure the absorption at 0na+.
本酵素の1単位(U)は、55℃で1分間当り1モルの
基質を分解する(1モルのArgを遊離する)ことので
きる酵素量とする。One unit (U) of the present enzyme is defined as the amount of enzyme capable of decomposing 1 mol of substrate (liberating 1 mol of Arg) per minute at 55°C.
本測定に用いるニンヒドリン試薬は、ニンヒドリン15
gをメチルセロソルブフ゛300 dで?審問したA液
と、0.OIM KCN 5dにメチルセロソルブ25
0111を溶解させたBWlとを1:5の比で混合して
調製する。The ninhydrin reagent used in this measurement is ninhydrin 15
g with methyl cellosolve 300 d? The tested liquid A and 0. OIM KCN 5d with methyl cellosolve 25
It is prepared by mixing BWl in which 0111 is dissolved at a ratio of 1:5.
か1鋲11資
以下の酵素の性質のうち、基質特異性、阻害、分子量、
等電点、およびKm値については後述の実施例により得
られる精製標品を用いて測定を行った。至適pH及び安
定pi(範囲、至適温度および熱安定性については、次
のようにして得られる部分精製標品を用いた。まず、菌
体抽出液に硫安を80%飽和で加え、得られた沈澱を、
100mM ) ’)スー塩酸(pH7,5)に対し透
析した。この透析内液を同緩衝液で平衡化したQ−セフ
ァロースに吸着させた後、溶出液のNaC1濃度を0〜
1Mに直線的に高めて溶出させ、部分精製標品を得た。Of the following 11 properties of enzymes, substrate specificity, inhibition, molecular weight,
The isoelectric point and Km value were measured using purified specimens obtained in Examples described later. For optimum pH and stable pi (range, optimum temperature and thermal stability, a partially purified sample obtained as follows was used. First, ammonium sulfate was added to the bacterial cell extract at 80% saturation. The precipitate was
It was dialyzed against 100mM) ') HCl (pH 7.5). After adsorbing this dialysate to Q-Sepharose equilibrated with the same buffer, the NaCl concentration of the eluate was adjusted to 0 to
A partially purified sample was obtained by elution linearly increasing to 1M.
■作用
カルボキシ末端がアルギニンまたはリシンであるペプチ
ドの該末端のアルギニンまたはリシンを、加水分解によ
り遊離させる。末端がアルギニンのペプチドに最もよく
作用する。(2) Action The arginine or lysine at the carboxy terminus of a peptide whose carboxy terminus is arginine or lysine is released by hydrolysis. It works best on peptides with arginine at the end.
■基質特異性
表1に示す合成ペプチドの分解性を調べた。まず、5%
エタノールを含む100d l−リス−塩酸(pi(
8,5)に各基質(合成ペプチド)を11の割合で加え
、55℃にわいて所定の時間反応させた。ニンヒドリン
法(活性測定法に準する)により生成した遊離アミノ酸
を定量することにより、基質分解速度を算出した。その
結果を表1に示す。■Substrate specificity The degradability of the synthetic peptides shown in Table 1 was investigated. First, 5%
100 d l-lis-hydrochloric acid (pi(
Each substrate (synthetic peptide) was added to 8,5) at a ratio of 11 parts, and reacted at 55°C for a predetermined time. The substrate decomposition rate was calculated by quantifying the free amino acids produced by the ninhydrin method (according to the activity measurement method). The results are shown in Table 1.
(以下余白)
表1から、本発明CPa5eB様酵素:よ、C末端がA
rgのペプチドを最もよく分解することがわかる。(Left below) From Table 1, it can be seen that the CPa5eB-like enzyme of the present invention: the C-terminus is A
It can be seen that the rg peptide is degraded best.
Argと同様に塩基性アミノ酸であるLysをC末端に
有するペプチドも比較的よく分解するが、その速度はA
rgの場合の約179であった。この点で、本酵素は、
CPa5e B、例えば、The EnzyIle、
3rd ed。Similar to Arg, peptides with the basic amino acid Lys at the C-terminus are also degraded relatively well, but the rate is slower than that of A.
It was about 179 for rg. In this respect, the enzyme is
CPa5e B, e.g. The EnzyIle,
3rd ed.
3、57−79(1971)に記載のCPa5e B
(この酵素は、末端か^rgのペプチドおよび末端がL
ysのペプチドを同程度の割合で分解する)と異なる。3, 57-79 (1971).
(This enzyme has a peptide with a terminal or ^rg and a peptide with a terminal L
ys peptide at a similar rate).
C末端から2番目のアミノ酸残基がPhe (芳香族ア
ミノ酸)であるペプチドの場合には、同程度の分解能が
認められるが、Gly、 Ala、 lie、 Leu
などの脂肪族アミノ酸の場合にはC末端のアミノ酸の種
類によりそれぞれ分解能が異なることがわかる。In the case of peptides in which the second amino acid residue from the C-terminus is Phe (aromatic amino acid), similar resolution is observed, but with Gly, Ala, lie, Leu
It can be seen that in the case of aliphatic amino acids such as, the resolution differs depending on the type of C-terminal amino acid.
次に、本酵素による各種天然ペプチドの分解を調べた。Next, we investigated the degradation of various natural peptides by this enzyme.
1Ill’lの基質を含む1抛門リン酸緩衛液(pH7
,5)中、55゛Cにおいて所定の時間酵素を反応させ
た。遊離したアミノ酸をアミノ酸分析計(日立高速アミ
ノ酸分析計835形)で測定した。その結果を表2に示
す。1 phosphate buffer solution (pH 7) containing 1 Ill'l of substrate.
, 5), the enzyme was allowed to react at 55°C for a predetermined period of time. The released amino acids were measured using an amino acid analyzer (Hitachi High Speed Amino Acid Analyzer Model 835). The results are shown in Table 2.
表2の結果と同様、C末端から2番目のアミノ酸残基が
Tyr、 Pheなど芳香族アミノ酸の場合には高い分
解活性が示された。これに対し、Alaでは173〜1
/4に活性が低下し、Leuではまったく分解が行こら
なかった。さらに、本CPa5e B様酵素はC末端か
ら2番目のアミノ酸残基がProの場合にも比較的良好
に分解が行われた。これは、上記TheEnzyr@e
に記載のCPa5e Bが、C末端から2番目がPro
であるペプチドをほとんど分解しないのとは大きく異な
る点である。Similar to the results in Table 2, high decomposition activity was shown when the second amino acid residue from the C-terminus was an aromatic amino acid such as Tyr or Phe. In contrast, Ala has 173 to 1
The activity decreased to /4, and no decomposition occurred at all with Leu. Furthermore, the CPa5e B-like enzyme degraded relatively well even when the second amino acid residue from the C-terminus was Pro. This is the above TheEnzyr@e
CPa5e B described in
This is a big difference from the fact that it hardly degrades peptides.
このように、本発明のCPa5e B様酵素は、Arg
、Lysなどの塩基性アミノ酸をC末端に有するペプチ
ドをよく分解するという点では従来のCPa5e Bと
同様であるが、次の点において異なることが明らかであ
る。Thus, the CPa5e B-like enzyme of the present invention
Although it is similar to conventional CPa5e B in that it effectively degrades peptides having basic amino acids such as , Lys, etc. at the C-terminus, it is clear that it differs in the following points.
(i)ArgをC末端に有するペプチドの方がLysを
C末端に有するペプチドの場合より10倍近く分解が速
い。(i) Peptides having Arg at the C-terminus are degraded nearly 10 times faster than peptides having Lys at the C-terminus.
(ii)C末端から2番目のアミノ酸がProであるペ
プチドについても比較的良好に分解が行なわれる。(ii) Peptides in which the second amino acid from the C-terminus is Pro are also degraded relatively well.
(iii ) C末端から2番目のアミノ酸が芳香族ア
ミノ酸の場合には、比較的良好に分解が行われる。(iii) When the second amino acid from the C-terminus is an aromatic amino acid, decomposition is relatively successful.
■至i!lpHおよび安定pH
本酵素を用い、pH6〜10の範囲のpl(条件下で活
性測定法に準じて酵素反応を行った。各pHにおける酵
素の相対活性を第1図に示す。第1図において、・はト
リス−塩酸、△はKHzPO4−NazHPO4、口は
ホウ酸’ KCI−NazCO:+、そして○はNaz
HPO4−クエン酸の各緩衝液を用いた結果を示す。第
1図から、至適pHは55℃において約8.5であるこ
とがわかる。■To i! lpH and Stable pH Using this enzyme, an enzymatic reaction was carried out according to the activity measurement method under conditions of pl (pH 6 to 10). The relative activity of the enzyme at each pH is shown in Figure 1. ,・ is Tris-hydrochloric acid, △ is KHzPO4-NazHPO4, and is boric acid KCI-NazCO: +, and ○ is Naz
The results using each buffer of HPO4-citric acid are shown. From FIG. 1, it can be seen that the optimum pH is about 8.5 at 55°C.
本酵素を所定のpHのBri tton−Robins
on緩衝液に2.76 X 10−’U/mlの割合に
溶解し、25℃で9時間保持した後に残存活性を測定し
た。その結果を第2図に示す。第2図から安定pH範囲
は、pH7,0から10.0であることがわかる。This enzyme was added to a Britton-Robins solution at a specified pH.
on buffer at a ratio of 2.76 x 10-'U/ml and maintained at 25°C for 9 hours, after which the residual activity was measured. The results are shown in FIG. It can be seen from FIG. 2 that the stable pH range is from pH 7.0 to 10.0.
■作用適温の範囲
本酵素を用いBz−Gly−Argを基質とし、30〜
70℃の範囲の温度条件下で、活性測定法に準して酵素
反応を行った。その相対活性を第3図に示す。第3図か
ら本酵素の至適温度は約55℃であることがわかる。■ Range of suitable temperature for action Using this enzyme and using Bz-Gly-Arg as a substrate,
Enzyme reactions were carried out under temperature conditions in the range of 70°C according to the activity assay method. The relative activities are shown in FIG. From FIG. 3, it can be seen that the optimum temperature for this enzyme is about 55°C.
■熱安定性
本酵素をpl(7,5,4℃にて保持したところ少なく
とも1年間は失活しなかった。pH7,5,55℃にて
4時間保持した後にも90%の残存活性を示巳な。■Thermostability When this enzyme was kept at pH 7, 5, and 4℃, it did not lose its activity for at least one year. Even after keeping it at pH 7, 5, and 55℃ for 4 hours, 90% of the residual activity remained. Demonstrative.
本酵素を2.76X10−’U/s+1の濃度でpH7
,5において、第4図に示す温度(55℃〜100℃)
にて15分間保持し、その残存活性を求めた。その結果
を第4図に示す。第4図から本酵素は、pH7,5で1
5分間保持したときに55℃まで安定であり、80℃以
上において完全に失活することがわかる。This enzyme was added at a concentration of 2.76X10-'U/s+1 at pH 7.
, 5, the temperature shown in Figure 4 (55°C to 100°C)
The remaining activity was determined by holding for 15 minutes. The results are shown in FIG. From Fig. 4, this enzyme is 1 at pH 7.5.
It can be seen that it is stable up to 55°C when held for 5 minutes and is completely inactivated at 80°C or higher.
■阻害
表3に示す化合物を0.7++Mの割合で含む10抛h
トリス−塩酸(pi(8,5)中で、本酵素(3,8X
1O−qU/ml)を10分間インキュベートした後
、残存活性を測定した。その結果を表3に示す。■Inhibition 10 hours containing the compounds shown in Table 3 at a ratio of 0.7++M
The enzyme (3,8X
10-qU/ml) for 10 minutes, the residual activity was measured. The results are shown in Table 3.
(以下余白)
表3
化合物
残存活性
(%)
ヨード酢酸
ヨードアセドア
N−エチルマレイ
TPCK”
MSFb
LCKC
ZPCK’
DTT”
EDTA ’
0−フェナンス口
PCMB’
リン
g:p
りU11!マーキlリーフヱニルスル本二フクアシフト
表3に示すように、本酵素はCPa5e Bと同様にE
DTA、 o〜フェナンスロリンなどの金属キレート則
で強く阻害された。このことから、本酵素はメタル酵素
であることが明らかである。しかし、本酵素はDTT、
PCMBによっても阻害されることから一3S結合、
−5H基も活性の発現に必要であると考えられる。従っ
て、同じ(メタル酵素であるCPa5eBとは異なる酵
素であると考えられる。(Leaving space below) Table 3 Compound residual activity (%) Iodoacetic acid iodoacetic acid N-ethyl malei TPCK" MSFb LCKC ZPCK'DTT" EDTA '0-Phenence mouth PCMB' Ringg:p RiU11! As shown in Table 3, this enzyme is similar to CPa5e B.
It was strongly inhibited by metal chelation rules such as DTA and o-phenanthroline. From this, it is clear that this enzyme is a metal enzyme. However, this enzyme is DTT,
Since it is also inhibited by PCMB, -3S binding,
It is believed that the -5H group is also necessary for the expression of activity. Therefore, it is considered to be a different enzyme from CPa5eB, which is the same metal enzyme.
次に、本酵素の活性に与える各種イオンの影響について
検討した。まず、1 mM EDTAを含む100mM
トリス−塩酸(pH7,5)に対し、酵素液を4℃で1
2時間透析し、次いで再度100mM トリス−塩酸(
pi(7,5)に対し透析を行ってEDTAを除去した
。これに表4に示す化合物を、所望のイオンが1mMと
なるような濃度で添加し、該酵素の活性を測定した。Next, we investigated the effects of various ions on the activity of this enzyme. First, 100mM containing 1mM EDTA
Add the enzyme solution to Tris-HCl (pH 7.5) at 4°C.
Dialyzed for 2 hours, then again in 100mM Tris-HCl (
EDTA was removed by dialysis against pi(7,5). The compounds shown in Table 4 were added thereto at a concentration such that the desired ion was 1 mM, and the activity of the enzyme was measured.
(以下余白) 表4 NaCI CoC1□ eSOa eCIz PbAc。(Margin below) Table 4 NaCI CoC1□ eSOa eCIz PbAc.
Zn5O。Zn5O.
gSOa
nC1z
CaC1t
aC1z
uSOa
HgC1゜
CdC1!
表4に示すように、試験した範囲内のイオン種では活性
化は認められず、むしろ阻害された。特にCoCl2を
添加した場合には活性化が著しく低下した。これは従来
のCPa5e Bと大きく異なる特徴である。gSOa nC1z CaC1t aC1z uSOa HgC1°CdC1! As shown in Table 4, no activation was observed for ionic species within the range tested, but rather inhibition. In particular, when CoCl2 was added, activation was significantly reduced. This is a feature that is significantly different from the conventional CPa5e B.
■分子量
トーヨーバールHW55Sを用いた、ゲルろ過による分
子量は約45万である。■Molecular weight The molecular weight determined by gel filtration using Toyovar HW55S is approximately 450,000.
■等電点
ファストゲルrEp3−9ヲ用いたファストシステム(
ファルマシア社製)を用い、pIカリブレジョンキット
pH2,5〜6.5をスタンダードとして本酵素の等電
点を測定した。その結果、本酵素の等電点は5.49で
あった。■Fast system using isoelectric point fast gel rEp3-9 (
The isoelectric point of the enzyme was measured using pI Calibresion Kit pH 2.5 to 6.5 as a standard. As a result, the isoelectric point of this enzyme was 5.49.
■Bz−Gly−Argに対するKIII値Bz−Gl
y−Argを基質として1001Mトリス−塩酸(pH
8,5)中で反応を行ない、K+s値を算出した。その
結果、Km値は0.59mMであった。■KIII value Bz-Gl for Bz-Gly-Arg
1001M Tris-HCl (pH
8,5), and the K+s value was calculated. As a result, the Km value was 0.59mM.
既欠1IIIλL較
本酵素と、これまでに報告されているCPa5e Bと
の比較を行なった結果、次の相違が明らかとなった。As a result of a comparison between the existing enzyme lacking 1IIIλL and CPa5e B that has been reported so far, the following differences were revealed.
■両酵素とも、塩基性アミノ酸であるArgまたはLy
sをC末端に有するペプチドの該末端のArgまたはL
ysを加水分解により特異的に遊離させる。■Both enzymes are basic amino acids Arg or Ly.
Arg or L at the terminal of a peptide having s at the C-terminus
ys is specifically released by hydrolysis.
本発明のCPa5e B様酵素は、Argを有する基質
に対して、より有利に働き、その分解速度は、Argを
有する基質に対する方がLysを有する基質に対するよ
りも約10倍速い。これに対して、従来のCPa5eB
は、ArgをC末端に有する基質およびLysをC末端
に有する基質に同程度に作用する。The CPa5e B-like enzyme of the present invention works more favorably on substrates containing Arg, and its degradation rate is about 10 times faster for substrates containing Arg than for substrates containing Lys. In contrast, the conventional CPa5eB
acts to the same extent on substrates with Arg at the C-terminus and substrates with Lys at the C-terminus.
0本酵素は、C末端から2番目のアミノ酸残基が芳香族
アミノ酸であるPheであるペプチド、および脂肪族ア
ミノ酸のうちProであるペプチドに作用して、比較的
良好にこれを分解する。これに対して、従来のCPa5
e Bはこれらの分解性が低い。This enzyme acts on peptides whose second amino acid residue from the C-terminus is Phe, an aromatic amino acid, and peptides whose second amino acid residue from the C-terminus is Pro, an aliphatic amino acid, and degrades them relatively well. In contrast, the conventional CPa5
e B has low degradability in these.
■両酵素とも金属酵素であるが、本酵素の場合にはCo
C1zまたはZn5O,による活性化が認められない。■Both enzymes are metalloenzymes, but in the case of this enzyme Co
No activation by C1z or Zn5O is observed.
さらにDTTまたはPCMBによっても阻害を受ける。It is also inhibited by DTT or PCMB.
これに対して、従来のCPa5e Bは、CoC1,ま
たはZnSO4による活性化が認められ、かっ、DTT
またはPCMBにより阻害を受けにくい。On the other hand, the conventional CPa5e B was recognized to be activated by CoC1 or ZnSO4, and was activated by DTT.
or less susceptible to inhibition by PCMB.
このように、本発明の酵素はペプチドのC末端のArg
またはLysを特異的に遊離するという性質については
、従来のCPa5e Bと同じである。しかしながら、
基質特異性、阻害剤に対する感受性という点で全く異な
る新規酵素である。従って、本酵素はCPa5e B様
酵素と命名された。In this way, the enzyme of the present invention has a C-terminal Arg
Alternatively, the property of specifically releasing Lys is the same as that of conventional CPa5e B. however,
It is a new enzyme with completely different substrate specificity and sensitivity to inhibitors. Therefore, this enzyme was named CPa5e B-like enzyme.
(以下余白) (実施例) 以下に本発明を実施例につき説明する。(Margin below) (Example) The invention will be explained below with reference to examples.
(A)菌体の培養
皮をむいて1 cm角に切ったじやがいも200gに対
し水を500d!加え、加熱・沸騰させて1時間抽出を
行った。冷却後、さらしでa、過を行い、最後↓こ、1
000dになるように蒸留水を加えた。このようにして
得られたポテトエキスに2%(−/ν)のシュークロー
スを添加し、ポテトエキス・シュークロース培地とした
。(A) Cultivation of bacterial cells Add 500 g of water to 200 g of peeled and cut potatoes into 1 cm cubes! The mixture was then heated and boiled to perform extraction for 1 hour. After cooling, pass through a, and finally ↓, 1.
Distilled water was added to make the solution 000d. 2% (-/v) sucrose was added to the potato extract thus obtained to prepare a potato extract/sucrose medium.
このポテトエキス・シュークロース培地を滅菌し、Ch
aetomium sp、 F−33株を植菌し、30
℃&こて3日間種培養を行った。別に、上記ポテトエキ
ス・シュークロース培地3.5!を52容のファーメン
タ−に入れ、120℃にて15分間殺菌を行った。This potato extract/sucrose medium was sterilized and Ch
aetomium sp, F-33 strain was inoculated, and 30
Seed culture was carried out at ℃ & trowel for 3 days. Separately, the above potato extract/sucrose medium is 3.5! was placed in a 52-volume fermenter and sterilized at 120°C for 15 minutes.
これに上記種培養した培養物300 dを加え、30℃
1攪拌数1100rp、通気量l!/Il】nの条件下
で培養を行った。酵素活性が最大となる培養45時間後
に、さらしとろ紙を用いた吸引ろ過により集菌を行い、
菌体70gを得た。Add 300 d of the above-mentioned seed culture to this, and heat at 30°C.
1 stirring number 1100 rpm, aeration amount 1! /Il]n conditions. After 45 hours of culture, when the enzyme activity reaches its maximum, bacteria were collected by suction filtration using exposed filter paper.
70 g of bacterial cells were obtained.
(B)酵素の単離および精製
この菌体70gに対しほぼ同量の海砂を加え乳鉢中で菌
体を破砕した。これに、1100Il1トリス−塩酸(
pH7,5) 200ifを加えて、しばらく放置し、
さらしとろ紙を用いた吸引ろ過を行い、ろ液(粗酵素抽
出液)200雌(全活性7.73X10−’U 、比活
性0.0232)を得た。以上の抽出操作は水冷下で行
った。(B) Isolation and Purification of Enzyme To 70 g of the bacterial cells, approximately the same amount of sea sand was added and the bacterial cells were crushed in a mortar. To this, 1100Il1 Tris-HCl (
pH 7,5) Add 200if and leave it for a while.
Suction filtration using exposed filter paper was performed to obtain a filtrate (crude enzyme extract) of 200 females (total activity 7.73×10-'U, specific activity 0.0232). The above extraction operation was performed under water cooling.
この粗酵素抽出液を用い、以下に述べるように精製を行
った。まず、粗酵素抽出液を、40〜60%飽和で硫安
分画し、酵素を沈澱物として回収した。Using this crude enzyme extract, purification was performed as described below. First, the crude enzyme extract was subjected to ammonium sulfate fractionation at 40 to 60% saturation, and the enzyme was recovered as a precipitate.
この沈澱物を100mM トリス−塩酸(pH7,5
)に溶解した後、4℃で一晩透析を行い、ひき続き、エ
タノール分画(40〜60%シ/ν)を行い、再び酵素
を沈澱物として回収した(全活性4.18X10−’U
、比活性?、64 ;収率54%)。This precipitate was dissolved in 100mM Tris-HCl (pH 7.5).
), dialysis was carried out overnight at 4°C, followed by ethanol fractionation (40-60% Si/ν), and the enzyme was again recovered as a precipitate (total activity 4.18 x 10-'U).
, specific activity? , 64; yield 54%).
この沈澱物を1100IIトリス−塩酸(pH6,0)
に溶解した後、同緩衝液に対し透析した。透析内液を、
あらかしめ同緩衝液で平衡化しておいたQ−セファロー
ス(1,6X 13cm ;ファルマシア社製)に吸着
させだ後、100mM トリス−塩酸(pH6,o
; 0.IM NaC1を含む)で、充分にカラムを洗
浄し、NaCIfi度を0.1Mから0.4Mに直線的
に高めることにより酵素を溶出させた。本酵素は溶離液
のNaCIfi度が0.3M付近から溶出された(全活
性3.39XlO−’U 、比活性40.8 ;収率4
4%)。This precipitate was dissolved in 1100II Tris-HCl (pH 6.0).
After dissolving in the same buffer, it was dialyzed against the same buffer. dialysis fluid,
After adsorption onto Q-Sepharose (1,6 x 13 cm; manufactured by Pharmacia) that had been equilibrated with the same buffer, 100 mM Tris-HCl (pH 6, o
; 0. The enzyme was eluted by washing the column extensively with IM NaC1 (containing IM NaCl) and increasing the NaClfi degree linearly from 0.1M to 0.4M. This enzyme was eluted when the NaCIfi degree of the eluent was around 0.3M (total activity 3.39XlO-'U, specific activity 40.8; yield 4
4%).
次に、活性画分を100mM トリス−塩酸(pH7
,5)に対して透析した後、あらかじめ同緩衝液で平衡
化したDEAE トーヨーパール650M (I X
9cm ;東ソー社製)カラムに吸着させた。0.1M
NaC1を含む100mM トリス−塩酸(pH7
,5)で充分に洗浄した後、0、目〜0.15M Na
C1の直線濃度勾配により、フラクション当り2Idず
つの溶出を行った。本CPa5e B様酵素はNaC1
濃度が0.12M付近から溶出されたく全活性2.60
X10−’U 、比活性144;収率34%)。Next, the active fraction was dissolved in 100mM Tris-HCl (pH 7).
, 5), DEAE Toyo Pearl 650M (I
It was adsorbed onto a 9 cm (manufactured by Tosoh) column. 0.1M
100mM Tris-HCl (pH 7) containing NaCl
, 5), then 0.0~0.15M Na
Elution of 2 Id per fraction was performed using a linear concentration gradient of C1. This CPa5e B-like enzyme is NaCl
The total activity was 2.60 as it was eluted from a concentration of around 0.12M.
X10-'U, specific activity 144; yield 34%).
溶出された活性画分を11001IIトリス−塩酸(p
H7,5,3M NaClを含む)に対して透析した後
、あらかしめ同緩衝液で平衡化しておいたブチルh −
ヨーパール650(IX9cm;東ソー社製)に吸着さ
せ、同緩衝液で洗浄した後、3MからOMにNaC1濃
度を直線的に減少させることにより酵素の溶出を行った
。本CPa5e B様酵素は、NaC11度が約1門の
付近で溶出された(全活性1.78X10−’U 、比
活性278.収率23%)。The eluted active fraction was treated with 11001II Tris-HCl (p
After dialysis against H7,5,3M NaCl), butyl h
After adsorption on Yopar 650 (IX9cm; manufactured by Tosoh Corporation) and washing with the same buffer, the enzyme was eluted by linearly decreasing the NaCl concentration from 3M to OM. This CPa5e B-like enzyme was eluted around 1 gate of NaC 11 degrees (total activity 1.78×10-'U, specific activity 278, yield 23%).
溶出された活性画分を100+aM トリス−塩酸(
pH7,5)に対して充分に透析し、その内液を、あら
かじめ同緩衝液で平衡化したQ−セファロース (1×
9cm;ファルマシア社製)に吸着させた。これを、0
.23MのNaC1を含む同緩衝液で洗浄した後、Na
C!濃度を0.23Mから0.4Mに直線的に高めた溶
離液を用いて酵素の溶出を行った。酵素活性はNaC1
濃度が約0.4門のときに完全に溶出された(全活性0
.618XIO−’U ;比活性170.収率8.0
%)。The eluted active fraction was dissolved in 100+aM Tris-HCl (
The internal solution was thoroughly dialyzed against Q-Sepharose (1×
9 cm; manufactured by Pharmacia). This is 0
.. After washing with the same buffer containing 23M NaCl, Na
C! Enzyme elution was performed using an eluent whose concentration was linearly increased from 0.23M to 0.4M. Enzyme activity is NaCl
It was completely eluted when the concentration was about 0.4 (total activity 0).
.. 618XIO-'U; specific activity 170. Yield 8.0
%).
さらに、溶出された活性画分を100mM トリス塩
酸(pH9,0)に対して透析した後、この透析内液を
同緩衝液で平衡化したDEAE )−ヨーバール650
M(0,5X5CI11、東ソー社製)に吸着させ、0
.18MNaClを含む同緩衝液で充分に洗浄した。酵
素の溶出は0.18Mから0.25MのNaClの直線
濃度勾配により行った。酵素活性はNaClJ度が約0
.2M付近に溶出されたく全活性0.274 Xl0−
’U 、比活性106;収率3.5%)。Furthermore, the eluted active fraction was dialyzed against 100mM Tris-HCl (pH 9,0), and the dialyzed solution was equilibrated with the same buffer.
M (0.5X5CI11, manufactured by Tosoh Corporation), and
.. It was thoroughly washed with the same buffer containing 18M NaCl. Enzyme elution was performed using a linear concentration gradient from 0.18M to 0.25M NaCl. Enzyme activity is about 0 NaClJ degree
.. Total activity eluted around 2M 0.274 Xl0-
'U, specific activity 106; yield 3.5%).
最後に、活性画分12−を限外濾過(アミコン8(50
型)を用いて2 txRに濃縮した。この濃縮酵素液を
、あらかしめ100mM トリス−塩酸(pH7,5
)で平衡化しておいたトーヨーパールHW 55Sカラ
ム(2,CX90cm、東ソー社製)にかけ、流速45
.6d/時間でフラクション当り2dづつを分取した(
全活性0.027 xLO−’U H比活性34.2
、収率0.35%)。Finally, the active fraction 12- was filtered by ultrafiltration (Amicon 8 (50
(type) to concentrate to 2 txR. This concentrated enzyme solution was mixed with 100mM Tris-HCl (pH 7.5).
) was applied to a Toyo Pearl HW 55S column (2, CX90cm, manufactured by Tosoh) at a flow rate of 45
.. 2 d/fraction was collected at 6 d/h (
Total activity 0.027 xLO-'U H specific activity 34.2
, yield 0.35%).
以上の一連の操作により、収率0.35%で比活性が1
470の精製酵素が得られた。この精製標品の純度をp
H7,5フアストゲル(ファルマシア社製)を用い検討
した結果、単一であることが明らかとなった。Through the above series of operations, the yield was 0.35% and the specific activity was 1.
470 purified enzymes were obtained. The purity of this purified sample is p
As a result of investigation using H7,5 Fast Gel (manufactured by Pharmacia), it became clear that it was single.
上記精製酵素、および部分精製酵素の性質を調べたとこ
ろ、「酵素の性質」の項に記載した各性質が確認された
。When the properties of the purified enzyme and partially purified enzyme were investigated, the properties described in the "Properties of Enzyme" section were confirmed.
(発明の効果)
本発明によれば、このように、新規なカルボキシペプチ
ダーゼB様酵素が得られる。この酵素は微生物起源であ
るため生産が容易である。さ呟こ、既知のカルボキシペ
プチダーゼとは基質特異性が異なるため、このような性
質のちがいを利用して、蛋白の一次構造決定用試薬など
、種々の用途に利用することが可能である。(Effects of the Invention) According to the present invention, a novel carboxypeptidase B-like enzyme is thus obtained. This enzyme is easy to produce because it is of microbial origin. Since it has different substrate specificity from known carboxypeptidases, it is possible to take advantage of this difference in properties and use it for various purposes, such as as a reagent for determining the primary structure of proteins.
4、 ゛の なi゛
第1図は本発明酵素の至適pHを示すグラフ;第2図は
該酵素の安定pH範囲を示すグラフ;第3図は該酵素至
適温度を示すグラフ;そして第4図は該酵素の安定範囲
を示すグラフである。4. Figure 1 is a graph showing the optimum pH of the enzyme of the present invention; Figure 2 is a graph showing the stable pH range of the enzyme; Figure 3 is a graph showing the optimum temperature of the enzyme; and FIG. 4 is a graph showing the stable range of the enzyme.
以上that's all
Claims (1)
ゼB様酵素。 (1)作用:カルボキシ末端がアルギニンまたはリシン
であるペプチドの該末端のアルギニンまたはリシンを、
加水分解により遊離させる。 (2)基質特異性:グリシル−グリシル−チロシル−ア
ルギニン、ブラジキニン、ニューロテンシン断片1−8
に作用し、C末端のアルギニンを加水分解により遊離さ
せる。 (3)至適pH:約8.5(トリス−塩酸緩衝液中)。 (4)至適温度:55℃ (5)pH安定性:25℃にて9時間保持した場合に、
pH7〜10において安定である。 (6)熱安定性:4℃、pH7.5にて保持すると、少
なくとも1年間は100%の活性を示す。 55℃で5時間加熱した場合に、90%の残存活性を示
す。 (7)分子量:ゲル濾過法により測定した場合の分子量
は約45万である。 (8)等電点:5.49 2、Chaetomium属由来である、請求項1に記
載の酵素。[Claims] 1. A carboxypeptidase B-like enzyme having the following physicochemical properties. (1) Effect: arginine or lysine at the carboxy terminus of a peptide whose carboxy terminus is arginine or lysine,
Released by hydrolysis. (2) Substrate specificity: glycyl-glycyl-tyrosyl-arginine, bradykinin, neurotensin fragment 1-8
and releases C-terminal arginine by hydrolysis. (3) Optimum pH: about 8.5 (in Tris-HCl buffer). (4) Optimum temperature: 55°C (5) pH stability: When kept at 25°C for 9 hours,
Stable at pH 7-10. (6) Thermal stability: When kept at 4°C and pH 7.5, it shows 100% activity for at least 1 year. It shows 90% residual activity when heated at 55°C for 5 hours. (7) Molecular weight: The molecular weight when measured by gel filtration method is about 450,000. (8) Isoelectric point: 5.49 2. The enzyme according to claim 1, which is derived from the genus Chaetomium.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP24478090A JP2957246B2 (en) | 1990-09-14 | 1990-09-14 | Microbial carboxypeptidase B-like enzyme |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP24478090A JP2957246B2 (en) | 1990-09-14 | 1990-09-14 | Microbial carboxypeptidase B-like enzyme |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH04126079A true JPH04126079A (en) | 1992-04-27 |
JP2957246B2 JP2957246B2 (en) | 1999-10-04 |
Family
ID=17123813
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP24478090A Expired - Lifetime JP2957246B2 (en) | 1990-09-14 | 1990-09-14 | Microbial carboxypeptidase B-like enzyme |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2957246B2 (en) |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6248590B1 (en) | 1998-02-27 | 2001-06-19 | Cytomation, Inc. | Method and apparatus for flow cytometry |
US6819411B1 (en) | 1997-01-31 | 2004-11-16 | Xy, Inc. | Optical apparatus |
US7024316B1 (en) * | 1999-10-21 | 2006-04-04 | Dakocytomation Colorado, Inc. | Transiently dynamic flow cytometer analysis system |
US7723116B2 (en) | 2003-05-15 | 2010-05-25 | Xy, Inc. | Apparatus, methods and processes for sorting particles and for providing sex-sorted animal sperm |
US7758811B2 (en) | 2003-03-28 | 2010-07-20 | Inguran, Llc | System for analyzing particles using multiple flow cytometry units |
US7772005B1 (en) | 1998-07-30 | 2010-08-10 | Xy, Llc | Method of establishing an equine artificial insemination sample |
US7838210B2 (en) | 2004-03-29 | 2010-11-23 | Inguran, LLC. | Sperm suspensions for sorting into X or Y chromosome-bearing enriched populations |
US7855078B2 (en) | 2002-08-15 | 2010-12-21 | Xy, Llc | High resolution flow cytometer |
US8211629B2 (en) | 2002-08-01 | 2012-07-03 | Xy, Llc | Low pressure sperm cell separation system |
US9879221B2 (en) | 2000-11-29 | 2018-01-30 | Xy, Llc | Method of in-vitro fertilization with spermatozoa separated into X-chromosome and Y-chromosome bearing populations |
US11230695B2 (en) | 2002-09-13 | 2022-01-25 | Xy, Llc | Sperm cell processing and preservation systems |
-
1990
- 1990-09-14 JP JP24478090A patent/JP2957246B2/en not_active Expired - Lifetime
Cited By (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6819411B1 (en) | 1997-01-31 | 2004-11-16 | Xy, Inc. | Optical apparatus |
US7929137B2 (en) | 1997-01-31 | 2011-04-19 | Xy, Llc | Optical apparatus |
US6589792B1 (en) | 1998-02-27 | 2003-07-08 | Dakocytomation Denmark A/S | Method and apparatus for flow cytometry |
US6248590B1 (en) | 1998-02-27 | 2001-06-19 | Cytomation, Inc. | Method and apparatus for flow cytometry |
US7772005B1 (en) | 1998-07-30 | 2010-08-10 | Xy, Llc | Method of establishing an equine artificial insemination sample |
US7024316B1 (en) * | 1999-10-21 | 2006-04-04 | Dakocytomation Colorado, Inc. | Transiently dynamic flow cytometer analysis system |
US9879221B2 (en) | 2000-11-29 | 2018-01-30 | Xy, Llc | Method of in-vitro fertilization with spermatozoa separated into X-chromosome and Y-chromosome bearing populations |
US8211629B2 (en) | 2002-08-01 | 2012-07-03 | Xy, Llc | Low pressure sperm cell separation system |
US7855078B2 (en) | 2002-08-15 | 2010-12-21 | Xy, Llc | High resolution flow cytometer |
US11261424B2 (en) | 2002-09-13 | 2022-03-01 | Xy, Llc | Sperm cell processing systems |
US11230695B2 (en) | 2002-09-13 | 2022-01-25 | Xy, Llc | Sperm cell processing and preservation systems |
US7799569B2 (en) | 2003-03-28 | 2010-09-21 | Inguran, Llc | Process for evaluating staining conditions of cells for sorting |
US11718826B2 (en) | 2003-03-28 | 2023-08-08 | Inguran, Llc | System and method for sorting particles |
US7758811B2 (en) | 2003-03-28 | 2010-07-20 | Inguran, Llc | System for analyzing particles using multiple flow cytometry units |
US10100278B2 (en) | 2003-03-28 | 2018-10-16 | Inguran, Llc | Multi-channel system and methods for sorting particles |
US11104880B2 (en) | 2003-03-28 | 2021-08-31 | Inguran, Llc | Photo-damage system for sorting particles |
US7723116B2 (en) | 2003-05-15 | 2010-05-25 | Xy, Inc. | Apparatus, methods and processes for sorting particles and for providing sex-sorted animal sperm |
US7838210B2 (en) | 2004-03-29 | 2010-11-23 | Inguran, LLC. | Sperm suspensions for sorting into X or Y chromosome-bearing enriched populations |
Also Published As
Publication number | Publication date |
---|---|
JP2957246B2 (en) | 1999-10-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH04126079A (en) | Carboxypeptidase b-like enzyme originated from microorganism | |
JPH0928376A (en) | New dipeptidyl peptidase iv and its production | |
JPS6247520B2 (en) | ||
JPS6322188A (en) | Novel l-aminoacylase | |
US4014860A (en) | Plasminostreptin (enzyme inhibitor) and method for producing it from streptomyces | |
Bannerman et al. | Isolation and characterization of an enzyme with esterase activity from Micropolyspora faeni | |
JPH0789920B2 (en) | Method for producing -α-N-acetylgalactosaminidase by microorganism | |
JPH07274944A (en) | New variant and method for producing protein hydrolysate | |
JPS58152481A (en) | Novel phospholipase d-p and preparation thereof | |
JP3820617B2 (en) | ε-Poly-L-lysine-degrading enzyme and method for producing ε-poly-L-lysine with low polymerization degree using the same | |
JP2885434B2 (en) | Protease and method for producing the same | |
JP2525592B2 (en) | Carboxypeptidase and method for producing the same | |
KR960014622B1 (en) | Culture ground for streptcoccus pneumoniae | |
JPS5867183A (en) | Production of phospholipase d | |
KR790000956B1 (en) | Preparation of bacillopeptidase "c" | |
JPS58164561A (en) | Novel physiologically active pentapeptide and its preparation | |
JP5515017B2 (en) | Method for decoloring coloring components using protease for decolorization | |
JP4085486B2 (en) | A novel lysine residue-specific enzyme-producing bacterium | |
KR100392175B1 (en) | thrombotic dissolving enzyme and its producing method originated in mushroom | |
JPH07106148B2 (en) | Novel enzyme having agarase activity, method for producing the same, and novel microorganism producing the enzyme | |
JPS61265088A (en) | Endo-beta-n-acetylglucosaminidase and production thereof | |
JPS61108393A (en) | Production of pyrogallol | |
JPS63116690A (en) | Production of novel microbial species acremonium sp 15 and beta-d-1,2-glucanase | |
JPS5995886A (en) | L-tryptophan aminopeptidase and its preparation | |
JPS58201987A (en) | Carboxypeptidase and its preparation |